Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BILIBILI-W
09626
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 289.91%147.76M | -14.16%830.62M | -14.59%158.19M | 4.56%402.24M | -0.76%347.99M | -265.12%-77.81M | 24.19%967.69M | 60.64%185.22M | 14.23%384.7M | 79.67%350.65M |
| Net income from continuing operations | 73.72%146.66M | -6.28%436.07M | -88.37%28.88M | -5.57%92.85M | 509.23%229.91M | 4.29%84.42M | 209.02%465.28M | 609.96%248.27M | 70.67%98.33M | -85.40%37.74M |
| Operating gains losses | 0.93%3.04M | 119.41%66M | 116.98%65.32M | -148.03%-8.75M | -51.01%6.42M | -77.41%3.01M | -298.15%-340.04M | -365.91%-384.7M | 116.58%18.22M | 23.73%13.11M |
| Depreciation and amortization | -0.77%159.69M | -20.63%641.24M | -9.46%160.84M | -11.98%159.36M | -26.59%160.13M | -30.37%160.92M | 22.91%807.93M | -22.59%177.65M | -4.94%181.04M | 86.17%218.12M |
| Asset impairment expenditure | --4.42M | -56.10%8.81M | 53.15%7.37M | -98.92%46K | -77.83%1.39M | --0 | 108.35%20.06M | 92.06%4.82M | 27.93%4.28M | 559.07%6.25M |
| Unrealized gains and losses of investment securities | -131.45%-7.84M | ---- | ---- | ---- | -219.50%-45.55M | 239.34%24.94M | -102.42%-3.12M | -140.97%-6.67M | -116.23%-16.67M | 122.21%38.12M |
| Remuneration paid in stock | -40.18%17.68M | -25.16%104.84M | -18.10%21.92M | -36.19%23M | -24.43%30.36M | -20.32%29.56M | 7.50%140.08M | -36.12%26.77M | -0.90%36.04M | 39.39%40.18M |
| Deferred tax | 64.10%-15.13M | 2.57%-138.62M | -143.82%-46.85M | 46.23%-38.79M | 87.75%-10.83M | 52.44%-42.15M | 4.87%-142.27M | 266.86%106.9M | 45.30%-72.14M | -238.24%-88.4M |
| Other non cashItems | 8.76%5.76M | -12.99%21.98M | -0.48%5.64M | -18.13%5.54M | -24.93%5.5M | -3.64%5.3M | 50.76%25.26M | -31.33%5.67M | 26.94%6.77M | 334.46%7.33M |
| Change In working capital | 51.57%-166.51M | -3,501.58%-309.7M | -53,662.66%-84.95M | 12.08%148.38M | -137.51%-29.34M | -56.96%-343.8M | 95.85%-8.6M | 99.91%-158K | 105.44%132.38M | 414.97%78.21M |
| -Change in receivables | 165.29%63.03M | -524.15%-55.81M | -316.00%-71.62M | -61.02%33.88M | 63.83%-41.83M | 171.89%23.76M | -86.16%13.16M | 303.32%33.16M | -44.44%86.91M | -21.11%-115.65M |
| -Change in prepaid assets | -109.46%-2.1M | 249.62%42.49M | 116.03%5.31M | -2,490.25%-17.4M | 311.43%32.43M | 14.62%22.15M | -23.27%-28.4M | -178.56%-33.11M | 101.17%728K | -11,607.63%-15.34M |
| -Change in payables and accrued expense | 16.49%-89.79M | 65.07%-23.01M | 732.80%58.3M | 289.24%46.8M | -127.07%-20.59M | 13.44%-107.52M | 48.16%-65.89M | -33.85%7M | 83.13%-24.73M | 110.44%76.06M |
| -Change in other current assets | 264.68%7.81M | -161.43%-15.26M | -140.47%-7.68M | -1,045.54%-6.15M | 196.77%3.31M | -215.55%-4.74M | 319.96%24.85M | 458.20%18.98M | -98.81%650K | 108.60%1.11M |
| -Change in other working capital | 47.57%-145.46M | -641.37%-258.1M | -164.45%-69.25M | 32.58%91.25M | -102.01%-2.66M | -118.47%-277.44M | 133.79%47.68M | 87.56%-26.19M | 10.89%68.82M | 177.35%132.03M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 289.91%147.76M | -14.16%830.62M | -14.59%158.19M | 4.56%402.24M | -0.76%347.99M | -265.12%-77.81M | 24.19%967.69M | 60.64%185.22M | 14.23%384.7M | 79.67%350.65M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -23.58%-45.03M | -107.47%-153.51M | -101.56%-34.09M | -28.24%-35.56M | -2.05%-47.42M | 27.70%-36.44M | 136.37%2.06B | 8,351.95%2.18B | 99.50%-27.73M | -40.44%-46.47M |
| Net PPE purchase and sale | -18.36%-46.53M | 10.09%-143.22M | 14.39%-34.23M | 22.24%-28.41M | 8.78%-41.27M | -4.73%-39.32M | -28.64%-159.3M | -66.16%-39.98M | -16.98%-36.54M | -40.43%-45.24M |
| Net business purchase and sale | ---- | -100.53%-11.69M | --0 | --0 | ---11.69M | --0 | 139.24%2.22B | 94,677.30%2.23B | --0 | --0 |
| Net investment purchase and sale | -65.46%870K | ---10.38M | --0 | -556.10%-12.9M | --0 | 28.13%2.52M | --0 | --0 | -101.50%-1.97M | --0 |
| Interest received (cash flow from investment activities) | ---- | 15.93%5.17M | --0 | ---- | ---- | ---- | --4.46M | --0 | ---- | ---- |
| Net other investing changes | 77.03%632K | 167.77%6.61M | 101.51%140K | -90.78%582K | 550.37%5.54M | 106.43%357K | -1,017.87%-9.76M | ---9.29M | --6.32M | ---1.23M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -23.58%-45.03M | -107.47%-153.51M | -101.56%-34.09M | -28.24%-35.56M | -2.05%-47.42M | 27.70%-36.44M | 136.37%2.06B | 8,351.95%2.18B | 99.50%-27.73M | -40.44%-46.47M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 4.77%-176.43M | 71.82%-834.68M | 87.56%-273.91M | 0.78%-225.65M | 36.48%-149.84M | 37.62%-185.27M | -167.27%-2.96B | -749.29%-2.2B | -106.00%-227.43M | -125.46%-235.9M |
| Net issuance payments of debt | 0.00%-8.96M | 98.60%-35.85M | 99.55%-8.96M | 95.19%-8.96M | 95.19%-8.96M | 95.19%-8.96M | -154.36%-2.57B | -977.41%-2.01B | -104.76%-186.46M | -118.69%-186.46M |
| Net common stock issuance | 4.25%-107.63M | -167.80%-543.91M | -37.17%-205.78M | ---119.7M | ---106.03M | -111.74%-112.4M | -826.60%-203.1M | -584.42%-150.02M | --0 | --0 |
| Cash dividends paid | 1.22%-68.22M | -1.56%-271.52M | 0.75%-66.19M | -0.99%-67.96M | -2.86%-68.31M | -3.13%-69.06M | -3.01%-267.36M | -2.49%-66.69M | -3.66%-67.29M | -2.39%-66.41M |
| Proceeds from stock option exercised by employees | -11.31%8.38M | -47.14%35.37M | -4.45%9.45M | -70.53%8.19M | -53.43%8.29M | -17.50%9.45M | 70.13%66.91M | -30.17%9.89M | 195.46%27.77M | 210.39%17.8M |
| Net other financing activities | ---- | -287.76%-18.77M | -117.06%-2.43M | -2,471.87%-37.22M | 3,128.52%25.17M | -119.02%-4.3M | 112.60%10M | 20,836.76%14.24M | 97.86%-1.45M | ---831K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 4.77%-176.43M | 71.82%-834.68M | 87.56%-273.91M | 0.78%-225.65M | 36.48%-149.84M | 37.62%-185.27M | -167.27%-2.96B | -749.29%-2.2B | -106.00%-227.43M | -125.46%-235.9M |
| Net cash flow | ||||||||||
| Beginning cash position | -9.72%1.16B | 3.96%1.28B | 13.52%1.28B | 11.81%1.12B | 8.70%1B | 3.96%1.28B | -27.24%1.23B | -19.45%1.13B | -64.38%1.01B | -45.96%922.15M |
| Current changes in cash | 75.39%-73.7M | -357.87%-157.57M | -191.57%-149.8M | 8.87%141.03M | 120.75%150.73M | 0.26%-299.52M | 113.02%61.1M | 196.04%163.59M | 109.08%129.53M | -93.73%68.28M |
| Effect of exchange rate changes | -77.50%4.31M | 368.14%32.88M | 438.32%28.02M | 294.92%14.66M | -292.33%-28.93M | 266.36%19.14M | -270.25%-12.26M | -281.16%-8.28M | -359.08%-7.52M | -45.95%15.04M |
| End cash Position | 8.61%1.09B | -9.72%1.16B | -9.72%1.16B | 13.52%1.28B | 11.81%1.12B | 8.70%1B | 3.96%1.28B | 3.96%1.28B | -19.45%1.13B | -64.38%1.01B |
| Free cash from | 186.43%101.23M | -14.97%687.4M | -14.65%123.97M | 7.37%373.83M | 0.43%306.72M | -1,322.31%-117.12M | 23.35%808.4M | 59.18%145.24M | 13.95%348.16M | 87.42%305.41M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.